» Articles » PMID: 29748432

The Sensitivity and Specificity of the Glucose Challenge Test in a Universal Two-Step Screening Strategy for Gestational Diabetes Mellitus Using the 2013 World Health Organization Criteria

Citing Articles

Fetal size monitoring in women with gestational diabetes and normal glucose tolerance.

Beunen K, Van den Abbeele F, Van Crombrugge P, Verhaeghe J, Vandeginste S, Verlaenen H Acta Diabetol. 2024; 62(1):35-48.

PMID: 39031189 DOI: 10.1007/s00592-024-02330-0.


Review of the Screening Guidelines for Gestational Diabetes Mellitus: How to Choose Wisely.

Bakshi R, Kumar A, Gupta V, Radhika A, Misra P, Bhardwaj P Indian J Community Med. 2024; 48(6):828-834.

PMID: 38249691 PMC: 10795887. DOI: 10.4103/ijcm.ijcm_298_23.


Normal glucose tolerant women with low glycemia during the oral glucose tolerance test have a higher risk to deliver a low birth weight infant.

Raets L, Van Doninck L, Van Crombrugge P, Moyson C, Verhaeghe J, Vandeginste S Front Endocrinol (Lausanne). 2023; 14:1186339.

PMID: 37334297 PMC: 10272607. DOI: 10.3389/fendo.2023.1186339.


The Belgian Diabetes in Pregnancy Follow-Up Study (BEDIP-FUS): A Multi-Centric Prospective Cohort Study on the Long-Term Metabolic Risk across Different Degrees of Gestational Glucose Intolerance: Methodology and Design.

Raets L, Van Hoorenbeeck K, Maes T, Vercammen C, De Block C, Dirinck E J Clin Med. 2023; 12(3).

PMID: 36769669 PMC: 9917817. DOI: 10.3390/jcm12031025.


Type 1 diabetes-related autoimmune antibodies in women with gestational diabetes mellitus and the long-term risk for glucose intolerance.

Beunen K, Vercauter L, Van Crombrugge P, Moyson C, Verhaeghe J, Vandeginste S Front Endocrinol (Lausanne). 2022; 13:973820.

PMID: 36093103 PMC: 9449803. DOI: 10.3389/fendo.2022.973820.